Using Data Management to Improve Population Health

It’s clear that a commitment to population health management is one of the platforms that PTS Diagnostics is built upon. At the heart (pun intended) of this value proposition is our PTS Connect® solutions, a biometric wellness management and reporting platform designed for the stewards of public health.

We recently upgraded our connectivity offerings through the announcement of, and subsequent growth plan for, two new products: PTS Connect® ProLink and PTS Connect® ScreenPro. These products fill a niche in two distinct markets.

Retail Pharmacies (PTS Connect ProLink)
Millions of people frequent grocery stores and pharmacies as a part of their weekly routines. While the number of grocery store and pharmacy visitors continues to rise, the percentage of people with a primary care physician has declined. A recent study by the Kaiser Family Foundation has found that nearly 30 percent of U.S. men do not have a primary care physician. Many view a routine doctor’s visit as an inconvenience that often goes to the wayside when schedules get busy.

This is particularly troublesome because regular medical tests are needed when it comes to identifying and managing those with diabetes, prediabetes and their comorbidities.

As point-of-care testing advancements expand access points to pharmacies and retail screening events, an ever-increasing number of consumers are turning to these frequented locations to meet their healthcare needs. Convenience, extended hours, and lower costs are just a few of the many reasons why they make ideal locations for routine health screenings and can have a massive impact in the management of chronic disease states.

The PTS Connect ProLink, synced with CardioChek® Plus or CardioChek® PA analyzers, allows retail screening event participants to walk away with a personalized, printed copy of their results in the same place where they may typically pick up prescriptions or make healthy food decisions. This is a potentially industry-changing win for the future of point-of-care testing and treatment.

Wellness Screening Events (PTS Connect ScreenPro)
During a health screening event, every minute counts. Time spent manually typing and transcribing patient information and test results can have a huge impact on efficiency and data integrity. This can ultimately mean fewer people treated, more transcription errors (a $30 billion a year healthcare problem), delayed reporting and dissatisfied participants who are unlikely to return to future events.

Participants want to leave a screening event with results they can understand and act upon. Unlike other systems, The PTS Connect ScreenPro does not require internet access and can deliver customized, printable, wellness reports in minutes, complete with company logos.

This solution allows screeners to serve more people and helps attendees to quickly receive crucial point-of-care tests and walk away with clear results that they can take to a doctor for actionable steps in their chronic disease management. A win-win for both parties.

As population health changes, our service offerings must as well. With the new PTS Connect platforms, biometric screening and data management are made more productive. Professionals in the event screening and retail screening industries can secure their data and accurately provide more clientele with accurate results. Is PTS Connect ProLink or PTS Connect ScreenPro the right solution for your organization? Visit our product page, view our sales sheets (PTS Connect ProLink and PTS Connect ScreenPro) or call 1-870-5610 to learn more about these new offerings.

Paul Dreier | Vice President, International Sales
Mr. Dreier’s tenure at PTS Diagnostics started in 2016 as the Senior Director of PTS Services. His role at PTS Diagnostics focuses on business development of the company’s informatics and non-device product lines. His software and technology experience includes more than 25 years in the life sciences and defense industries. Starting as a chemist, he grew to love software and analytical instrumentation, eventually moving into companies that focus on those products. With global experience in more than 45 countries, Mr. Dreier’s past positions include VP, General Manager, and various executive and equity-based management positions in product management and development, sales, and marketing. Mr. Dreier earned a Bachelor of Science from Elmhurst College, and a Master of Business Administration in International Strategies from The Ohio State University.

Michael Hewitt | Product Manager
Michael Hewitt is a Product Manager for PTS Diagnostics, the manufacturer of A1CNow+ systems, CardioChek®  family of products and the PTS Detect™ cotinine system. Mike manages the PTS Connect®  product portfolio and helps customers across the globe implement PTS Connect® ​ solutions, a digital population health management platform that makes biometric connectivity flexible and information management simple. 

National Diabetes Month Highlights Importance of Point-of-Care Testing

​November is National Diabetes Month in the United States and throughout the month, our social media channels will be focused on providing information about the management and diagnosis of both diabetes and prediabetes.

So, what is diabetes? Put simply, it’s a disease that prohibits one’s body from converting the glucose from food into energy. It occurs in the pancreas but can impact nearly all of the vital organs.

According to the Centers for Disease Control and Prevention, one in 10 Americans has diabetes. Perhaps even more startling, many at risk of becoming diabetics don’t even know it. A recent study published in JAMA finds that only 12 percent of those with prediabetes know that they have it and that half of all adults in the U.S. are either prediabetic or diabetic.

An effective way of managing both diabetes and prediabetes is through point-of-care testing. With quick lipid, glucose and A1C measurements, physicians are able to quickly interpret results and use office-time to have a meaningful conversation about effective disease management methods.

Moreover, point-of-care testing also increases the rate of diagnosis by eliminating the risk of patient’s failing to complete lab testing or not coming back to their physician’s office for follow-up appointments. A 2011 study by Kaiser found that the average turnaround time for lab results is 25-30 days; a delay in diagnosis that can have a negative impact on diabetics and prediabetics.

At PTS Diagnostics, we understand that diabetes and prediabetes diagnosis can be overwhelming, so we’ve compiled online resources for disease management and support.

We encourage everyone to ask their primary care physician about their diabetes risk and the benefits of point-of-care testing. To learn more about our specialized point-of-care solutions and our commitment to helping diabetics, connect with PTS.

MACRA's Impact on Point-of-Care

Rising medical costs and the evolving complexity of healthcare delivery has caused some providers and patients to think outside of the box when it comes to cost-effective coverage.

Healthcare’s standard Fee-For-Service (FFS) model compensates physicians, hospitals, clinics, etc. strictly based on the quantity and complexity of the services they provide.

The Medicare Access and CHIP Reauthorization Act (MACRA) differs in that it rewards healthcare providers through Merit Based Incentives (MIPS) and Advanced Payment Models (APMs) that give financial benefits based on the quality and efficiency of their care.


 Point-of-care medical devices align seamlessly into this new age healthcare model by improving the turnaround time for test results when compared to outside labs; revolutionizing the way that providers interact with patients.

Since patient care providers can interpret glucose, A1C and cholesterol levels in just minutes, they’re often able to develop a treatment plan immediately, allowing for more meaningful dialogues with their patients. This can help improve a patient’s quality of life by allowing them to more quickly make informed decisions about diet, exercise and lifestyle.

Healthcare organizations throughout the United States are beginning to take notice of the importance of efficiency. According to the 2016 Health Industry Distributors Association Patient Satisfaction Survey, 52 percent of acute care providers are actively planning to decrease the turnaround time for medical tests within the next two years.

When disease management moves as fast as the rest of our lives, it can become a part of our lives. For more information about point-of-care technology, learn more about PTS Diagnostics.

Jeff Stebbins | Head of Payer Strategy and Marketing

The Importance of Proficiency Testing

​It’s rewarding to work for a comprehensive point-of-care diagnostics company that designs and manufactures products used for testing cardiovascular heart disease, diabetes and more. Anyone who’s ever been impacted by these diseases knows how important fast and accurate test results are. Accurate results aid in physician decisions and in many cases can provide peace of mind for those undergoing routine laboratory testing.

Healthcare providers in 135 countries trust the CardioChek® and A1CNOW® to help in diagnosing and treating patients at the point-of-care. Ensuring that these analyzers perform and produce quality results is a top priority. One of the most important aspects to my role as Director of Clinical Laboratory Medicine is to give our customers confidence in our analyzers and results.

​Verifying that our technology works correctly can identify potential testing issues. Proficiency testing is a part of a quality assurance program that reassures the accurate performance of our products. It’s an effective tool because it not only tests our analyzers, but the testing process itself. Even though it’s not required in most states, we encourage all of our customers to pursue proficiency testing through American Proficiency Institute. This third-party proficiency testing program provides an extra boost of confidence in PTS Diagnostic’s analyzers and their results to patients and physicians.

All of our analyzers are eligible for proficiency testing. The biggest takeaway that I want to leave with decision makers at medical facilities is that proficiency testing is just one more arrow in your quiver. It gives confidence in the ability of a test system to provide quality results and can help to proactively identify any potential issues that could be seen down the road. This is why I believe proficiency testing is an important quality assurance tool for our A1CNOW+ and CardioChek systems.

I encourage anyone with questions about beginning this process to connect with us to learn more about PTS Diagnostics

Carrie Szablowski | Director of Clinical Laboratory Medicine